Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Canakinumab Versus Placebo in Combination With First-Line Pembrolizumab Plus Chemotherapy for Advanced Non–Small-Cell Lung Cancer: Results From the CANOPY-1 Trial
PaperCitations, authors & open-access status
Canakinumab Versus Placebo in Combination With First-Line Pembrolizumab Plus Chemotherapy for Advanced Non–Small-Cell Lung Cancer: Results From the CANOPY-1 Trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 83 citations, 2023 year and closed oa status.
83
Citations
2023
Year
closed
OA Status